Johns Hopkins HIV Guide
Daunorubicin Citrate Liposome Injection
INDICATIONS
FDA
FDA
- Treatment of advanced HIV-associated Kaposi’s sarcoma (KS)
There's more to see -- the rest of this topic is available only to subscribers.
Last updated: January 5, 2017
Citation
Smith, Janessa, and Paul A Pham. "Daunorubicin Citrate Liposome Injection." Johns Hopkins HIV Guide, The Johns Hopkins University, 2017. Johns Hopkins Guides, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545052/all/Daunorubicin_Citrate_Liposome_Injection.
Smith J, Pham PA. Daunorubicin Citrate Liposome Injection. Johns Hopkins HIV Guide. The Johns Hopkins University; 2017. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545052/all/Daunorubicin_Citrate_Liposome_Injection. Accessed October 4, 2025.
Smith, J., & Pham, P. A. (2017). Daunorubicin Citrate Liposome Injection. In Johns Hopkins HIV Guide. The Johns Hopkins University. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545052/all/Daunorubicin_Citrate_Liposome_Injection
Smith J, Pham PA. Daunorubicin Citrate Liposome Injection [Internet]. In: Johns Hopkins HIV Guide. The Johns Hopkins University; 2017. [cited 2025 October 04]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545052/all/Daunorubicin_Citrate_Liposome_Injection.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Daunorubicin Citrate Liposome Injection
ID - 545052
A1 - Smith,Janessa,Pharm.D. BCPS
AU - Pham,Paul,Pharm.D.
Y1 - 2017/01/05/
BT - Johns Hopkins HIV Guide
UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_HIV_Guide/545052/all/Daunorubicin_Citrate_Liposome_Injection
PB - The Johns Hopkins University
DB - Johns Hopkins Guides
DP - Unbound Medicine
ER -
